With a view to expanding access to Covid-19 drugs around the world, American pharmaceutical firm Pfizer announced it will allow generic manufacturers to supply its experimental Covid-19 antiviral pill PF-07321332 in 95 developing countries, including eight in Latin America.
Following the deal, Belize, Bolivia, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, and Venezuela will have access to the medication, which can reduce the risk of death by Covid-19 in patients with pre-existing conditions by up to 90 percent, when combined with low doses of ritonavir, an HIV drug that is already available as a generic medication.
The Pfizer deal comes at a time when cases are rebounding in countries such as Bolivia, which has only managed to fully vaccinate 33 percent of its adult population so far, according to Our World in Data.
The Ibre-FGV GDP monitor, a tool to predict economic activity in Brazil, suggests that the…
The floods in the Brazilian state of Rio Grande do Sul have killed nearly 150…
Home to the largest tropical forest in the world, an energy mix that is high…
The northeastern Brazilian state of Piauí isn’t among the country’s richest or most populous states…
Rio Grande do Sul Lieutenant-Governor Gabriel Souza said the state government is considering relocating entire…
“We’ve got no idea what the next vintage is going to look like. A lot…